Almirall aims to file once daily aclidinium bromide for COPD in Europe in early 2010

· In two 12-month Phase III studies aclidinium bromide showed a consistent and sustained improvement in pulmonary function together with improved symptom control and quality of life in patients with chronic obstructive pulmonary disease (COPD)

The release as fetched from its publisher. almirall.com ↗